Cadrenal Therapeutics, Inc. Common Stock (CVKD) vs Moolec Science S.A. (MLEC)

A side-by-side comparison of Cadrenal Therapeutics, Inc. Common Stock and Moolec Science S.A. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Cadrenal Therapeutics, Inc. Common Stock logo
CVKD
Cadrenal Therapeutics, Inc. Common Stock
$3M
$0.96HealthcareDelayed quote: Oct 6, 2026, 12:45 PM EDT
Moolec Science S.A. logo
MLEC
Moolec Science S.A.
$3M
$4.68HealthcareDelayed quote: Oct 6, 2026, 12:38 PM EDT

Total return — CVKD vs MLEC

growth of $100 · dividends reinvested · last 4y
CVKD -98.5% (-64.8%/yr)MLEC -99.4% (-72.3%/yr)CVKD compounded faster over this window
050100Start $100202420252026$2$1
CVKD MLEC

CVKD vs MLEC: by the numbers

  • •CVKD is the larger company ($3M vs $3M market cap).
  • •Both run net losses; CVKD's is the smaller (0.00% vs -105.71% net margin).

Metrics side by side

Valuation

MetricCVKDMLEC
P/B ratio0.84N/A

Profitability

MetricCVKDMLEC
Gross margin0.00%34.17%
Operating margin0.00%-3.14%
Net margin0.00%-105.71%
ROE-282.13%-89.85%
ROIC-284.81%-33.50%

Growth (annualized)

MetricCVKDMLEC
Total return CAGR (5Y)N/A-68.13%

Go deeper

Full CVKD analysisFull MLEC analysisInteractive comparison tool

Dig into the metrics

Cadrenal Therapeutics, Inc. Common Stock ROEMoolec Science ROECadrenal Therapeutics, Inc. Common Stock operating marginMoolec Science operating marginCadrenal Therapeutics, Inc. Common Stock revenue growthMoolec Science revenue growthCadrenal Therapeutics, Inc. Common Stock free cash flowMoolec Science free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.